NCT07033689 2026-04-03Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)SONIRE Therapeutics Inc.Phase EARLY_PHASE1 Recruiting10 enrolled
NCT07089940 2026-03-23OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Recruiting12 enrolled